State Of Wisconsin Investment Board Inozyme Pharma, Inc. Transaction History

State Of Wisconsin Investment Board

  • $37.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.05 - $2.82 $11,655 - $31,302
-11,100 Reduced 22.75%
37,700 $39,000
Q3 2022

Nov 14, 2022
SELL
$2.57 - $5.45 $51,657 - $109,545
-20,100 Reduced 29.17%
48,800 $131,000
Q2 2022

Aug 15, 2022
BUY
$3.2 - $5.96 $220,480 - $410,644
68,900 New
68,900 $329,000
Q2 2021

Aug 12, 2021
SELL
$15.19 - $21.2 $173,166 - $241,680
-11,400 Closed
0 $0
Q4 2020

Feb 03, 2021
BUY
$19.95 - $27.55 $227,430 - $314,070
11,400 New
11,400 $235,000

Others Institutions Holding INZY

# of Institutions
89
Shares Held
53.1M
Call Options Held
3.7K
Put Options Held
5.8K
View Full List

About Inozyme Pharma, Inc.

INZY Quotes by TradingView
  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $53M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email